Literature DB >> 28608527

Perfect storm: Therapeutic plasma exchange for a patient with thyroid storm.

Andrea M McGonigle1,2, Aaron A R Tobian1,2, Jennifer L Zink2, Karen E King1,2.   

Abstract

Thyroid storm is a potentially lethal complication of hyperthyroidism with increased thyroid hormones and exaggerated symptoms of thyrotoxicosis. First-line therapy includes methimazole (MMI) or propylthiouracil (PTU) to block production of thyroid hormones as a bridge toward definitive surgical treatment. Untreated thyroid storm has a mortality rate of up to 30%; this is particularly alarming when patients cannot tolerate or fail pharmacotherapy, especially if they cannot undergo thyroidectomy. Therapeutic plasma exchange (TPE) is an ASFA category III indication for thyroid storm, meaning the optimum role of this therapy is not established, and there are a limited number of cases in the literature. Yet TPE can remove T3 and T4 bound to albumin, autoantibodies, catecholamines and cytokines and is likely beneficial for these patients. We report a patient with thyroid storm who could not tolerate PTU, subsequently failed therapy with MMI, and was not appropriate for thyroidectomy. TPE was therefore performed daily for 4 days (1.0 plasma volume with 5% albumin replacement and 2 U of plasma). Over the treatment course, the patient's thyroid hormones normalized and symptoms of thyroid storm largely resolved; his T3 decreased from 2.27 to 0.81 ng/mL (normal 0.8-2.0), T4 decreased from 4.8 to 1.7 ng/mL (0.8-1.8), heart rate normalized, altered mental status improved, and he converted to normal sinus rhythm. He was ultimately discharged in euthyroid state. He experienced no side effects from his TPE procedures. TPE is a safe and effective treatment for thyroid storm when conventional treatments are not successful or appropriate.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  hyperthyroidism; methimazole (MMI); propylthiouracil (PTU); therapeutic apheresis; thionamide; thyrotoxicosis

Mesh:

Year:  2017        PMID: 28608527     DOI: 10.1002/jca.21560

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  2 in total

1.  THERAPEUTIC PLASMA EXCHANGE AS A BRIDGE TO TOTAL THYROIDECTOMY IN PATIENTS WITH SEVERE THYROTOXICOSIS.

Authors:  Kelsey Tieken; Ameena Madan Paramasivan; Whitney Goldner; Ana Yuil-Valdes; Abbey L Fingeret
Journal:  AACE Clin Case Rep       Date:  2020-09-26

2.  Preoperative Therapeutic Plasma Exchange and Surgical Treatment in Thyrotoxicosis Patients: A Single-Centre Retrospective Cohort Study.

Authors:  H Yabanoglu; R Sari; F Eksi Haydardedeoglu; M Kus; A S Hargura; I M Arer
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.